€61.35 -0.4 -0.6%
Last Trade - 4:35pm
| Market Cap | £4.06bn |
| Enterprise Value | £8.18bn |
| Revenue | £3.54bn |
| Position in Universe | 123rd / 846 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 4,086 | 1,985 | 2,181 | 3,440 | 4,366 | 4,681 | 4,507 | 4,731 | +2.8% | ||
| -49.9 | +64.8 | |||||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Eurazeo SE is a France-based investment company. The Company owns a diversified portfolio of over 18 billion euro in assets under management in all business sectors, including 12,9 billion euro from third parties, invested in over 430 companies. The Company is active through five investment divisions: Eurazeo Capital with investments in Iberchem, Albingia or Europcar Mobility Group; Eurazeo PME with investments in Dessange or In’Tech Medical; Eurazeo Growth with investments in Doctolib or PayFit; Eurazeo Brands with investments in consumer and retail, including beauty with Pat McGrath Labs, fashion with Bandier, home with Herschel Supply, leisure, wellness or food companies with Q Mixers; Eurazeo Patrimoine with investments in real estate and infrastructure with C2S Group, Dazeo or Reden Solar. The Company supports also digital sector with Idinvest Venture through investments in Ornikar, an online driving school or M Pharma, a biopharmaceutical company.
| Last Annual | December 31st, 2019 |
| Last Interim | June 30th, 2020 |
| Incorporated | January 1, 1969 |
| Public Since | January 7, 1985 |
| No. of Shareholders: | n/a |
| No. of Employees: | 22,361 |
| Sector | Financials |
| Industry | Investment Banking & Investment Services |
| Index | CAC Mid & Small , CAC All-tradable , FTSE Euromid , Sbf 120 Eclaireur , |
| Exchange | Euronext - Paris |
| Shares in Issue | 75,807,044 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 1 Rue de Georges Berger, PARIS, 75017, France |
| Web | https://www.eurazeo.com/ |
| Phone | +33 1 44150111 |
| Contact | Caroline Cohen (Contact Investor Relations) |
| Auditors | MAZARS |
As of 4:35pm, shares in Eurazeo SE are trading at €61.35, giving the company a market capitalisation of £4.06bn. This share price information is delayed by 15 minutes.
Shares in Eurazeo SE are currently trading at €61.35 and the price has moved by -2.53% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Eurazeo SE price has moved by -6.84% over the past year.
Of the analysts with advisory recommendations for Eurazeo SE, there are there are currently 4 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Eurazeo SE is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Eurazeo SE is scheduled to issue upcoming financial results on the following dates:
Eurazeo SE does not currently pay a dividend.
Eurazeo SE does not currently pay a dividend.
Eurazeo SE does not currently pay a dividend.
To buy shares in Eurazeo SE you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Eurazeo SE are currently trading at €61.35, giving the company a market capitalisation of £4.06bn.
Here are the trading details for Eurazeo SE:
Based on an overall assessment of its quality, value and momentum, Eurazeo SE is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Eurazeo SE are currently priced at €61.35. At that level they are trading at 5.96% discount to the analyst consensus target price of 0.00.
Analysts covering Eurazeo SE currently have a consensus Earnings Per Share (EPS) forecast of -1.974 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Eurazeo SE. Over the past six months, the relative strength of its shares against the market has been 23.01%. At the current price of €61.35, shares in Eurazeo SE are trading at 24.25% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Eurazeo SE.
Eurazeo SE's management team is headed by:
Here are the top five shareholders of Eurazeo SE based on the size of their shareholding:
